跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
OLUMIANT
Authorized
STANDARD
OLUMIANT
eli lilly canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
fab21fe8726fcf27
Company
eli lilly canada inc
Type
Standard
Approval Details
Approval Id
fab21fe8726fcf27
Drug Approval Canada Name
OLUMIANT
Product Name
OLUMIANT
Status
Marketed
Status Date
2024-04-09
Original Market Date
2024-04-09
Din
02544768
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
90:24.12.92
Atc Original
L04AF02 BARICITINIB
Atc Name
l 04 af 02
Aig Number
0160570002
Company Name
eli lilly canada inc
Company Address
SUITE 900, Exchange Tower, 130 King Street West, Toronto, Ontario, Canada, M5X 1B1
Active Ingredients
BARICITINIB
4 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
fab21fe8726fcf27
Type
Standard
Back to Health Canada Approvals
OLUMIANT - Health Canada Drug Approval Details